BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10381045)

  • 1. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome.
    Haga HJ; Rygh T
    J Rheumatol; 1999 Jun; 26(6):1291-5. PubMed ID: 10381045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA rheumatoid factor in primary Sjogren's syndrome.
    Peen E; Mellbye OJ; Haga HJ
    Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
    Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
    J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
    Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
    Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
    Huo AP; Lin KC; Chou CT
    Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
    Tishler M; Yaron I; Shirazi I; Yaron M
    J Rheumatol; 2001 Apr; 28(4):795-7. PubMed ID: 11327252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B virus infection in Sjögren's syndrome. Prevalence and clinical significance in 603 patients.
    Marcos M; Alvarez F; Brito-Zerón P; Bove A; Perez-De-Lis M; Diaz-Lagares C; Sanchez-Tapias JM; Ramos-Casals M
    Autoimmun Rev; 2009 Jun; 8(7):616-20. PubMed ID: 19393197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
    Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
    Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
    Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
    Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
    J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome.
    Walker J; Gordon T; Lester S; Downie-Doyle S; McEvoy D; Pile K; Waterman S; Rischmueller M
    J Rheumatol; 2003 Nov; 30(11):2406-12. PubMed ID: 14677185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid levels in Sjögren's syndrome.
    Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
    Rheumatology (Oxford); 2006 Apr; 45(4):481-4. PubMed ID: 16303821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study.
    Coates T; Slavotinek JP; Rischmueller M; Schultz D; Anderson C; Dellamelva M; Sage MR; Gordon TP
    J Rheumatol; 1999 Jun; 26(6):1301-5. PubMed ID: 10381047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
    Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
    Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations.
    Sirois DA; Natelson B
    J Rheumatol; 2001 Jan; 28(1):126-31. PubMed ID: 11196514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
    Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
    Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.